MBI community mourning the loss of Dr. Mavis Agbandje-McKenna
Dr. Agbandje-McKenna, a structural biologist whose widely recognized work led to advances in gene therapy treatments, has died at age 57.
Dr. Agbandje-McKenna, a structural biologist whose widely recognized work led to advances in gene therapy treatments, has died at age 57.
Learn how a new fund is propelling the ALS research of Drs. Emily Plowman and James Wymer.
Voices of those who’ve lost loved ones to brain cancer were prominent during this year’s UF Health-led ReMission Summit.
A named annual award is being created to exemplify Dr. Sarah Johnson's passion for research & dedication to mentorship.
Dr. Michael Okun co-authored journal Neurology review detailing a screening process to identify Tourette patients likely to benefit from DBS.
New research provides insight into how a variety of factors might be linked to the development of Parkinson’s disease.
Preclinical study shows potential to reverse pathological tau formations.
Leading cognitive aging expert has served as interim chair since April 2020.
Genetic and environmental factors in Parkinson’s converge on immune function and inflammation.
Electrical stimulation shows promise for restoring breathing after drug overdose, spinal cord injury in preclinical research.